Last ¥3,650 JPY
Change Today -80.00 / -2.14%
Volume 408.8K
6869 On Other Exchanges
As of 2:00 AM 07/10/14 All times are local (Market data is delayed by at least 15 minutes).

sysmex corp (6869) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/1/14 - ¥3,885
52 Week Low
02/5/14 - ¥2,600
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SYSMEX CORP (6869)

Related News

No related news articles were found.

sysmex corp (6869) Related Businessweek News

No Related Businessweek News Found

sysmex corp (6869) Details

Sysmex Corporation, together with its subsidiaries, engages in the research and development, production, sale, service, and support of diagnostic instruments, reagents, and software worldwide. The company provides diagnostics products for use in the areas of hematology, hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care testing; and laboratory information systems, including La-vietal LS, a clinical testing instrument system that links clinical testing instruments and other systems to provide an efficient operating environment. It also offers particle characterization analyzer products, including FPIA-3000 Flow Particle Image Analyzer, which offers automated analysis of particle size and shape; FPIA-3000 Darkfield unit to analyze samples, such as drugs, mica, and biological cells; and XT-2000iV, an animal blood cell analysis software used in the hematological analysis of laboratory veterinary animals, such as rats, mice, or dogs. In addition, the company provides life sciences solutions comprising automated gene amplification detector, a system for the detection of lymph node metastasis based on the one-step nucleic acid amplification method used for the diagnosis of breast, colon, and stomach cancer lymph node diagnosis in hospitals and other facilities, as well as a laboratory testing service for research involving the risk of recurrence of early-stage breast cancer. Further, it offers ASTRIM SU, a peripheral artery monitoring device that measures hemoglobin levels without blood sampling and is used in fitness centers and various other sites, as well as sells health management support software, which supports health check services at drug-stores and in the healthcare sections of other shops. The company was formerly known as TOA Medical Electronics Co., Ltd., and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.

5,401 Employees
Last Reported Date: 06/20/14
Founded in 1968

sysmex corp (6869) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

sysmex corp (6869) Key Developments

Sysmex Corporation Opens i-Square, a New Instrument Factory in the City of Kakogawa, Hyogo Prefecture

Sysmex Corporation has opened i-Square, a new instrument factory located in the city of Kakogawa, Hyogo Prefecture. Aimed at meeting growing global demand for in-vitro diagnostic (IVD) instruments, through this factory and the expansion of factories at two affiliated companies, the Sysmex Group will increase production capacity in stages-to triple the previous level. i-Square will serve as the Sysmex Group's core instrument factory, manufacturing high-end models efficiently. In addition, the new factory will support each of the others and lead reinforcement initiatives to enhance the Group's overall instrument manufacturing technologies. To respond to the needs of customers throughout the world in a timely manner, the new factory is also equipped with a warehousing function. Container packaging and customs procedures can all be handled in an integrated manner, facilitating export through the Port of Kobe and ensuring increasingly efficient logistics.

Sysmex and Toppan Printing to Collaborate in the Genetic Analysis Testing Industry

Sysmex Corp. and Toppan Printing Co., Ltd. have entered into an agreement to cooperate for advancement in the genetic analysis testing industry, and to invest in RIKEN GENESIS Co., Ltd. The companies will accelerate their approach to personalised medicine by fostering their technological synergies. In personalised medicine, gene detection technologies and bioinformatics 1 are playing an important role in providing the most appropriate medical care to respective patients. They do this by analyzing detected gene information to help determine individual conditions such as clinical progress and responsiveness to drug therapies.

Sysmex Corp. Launches LIASAUTO P-FDP Hemostasis Reagent

Sysmex Corp. announced that it is launching new reagent, LIASAUTO P-FDP, for the hemostasis field that can be used in its CS-Series of fully automated coagulation analyzers, as well as the CA-7/8000, CA-1500, CA-6/550 and Coagrex-800. This FDP 1 test reagent allows for a broad scope of testing and lowers the percentage of testing that requires repetition, thereby reducing reporting times and costs. The reagent can also be used in conjunction with a D-dimer 1 test to diagnose disseminated intravascular coagulation (DIC) 2 and in the selection of appropriate treatment methods. Aimed at providing utility in a clinical setting in these ways, the reagent heightens reactivity to fibrinogen degradation products. Sysmex’s new product LIASAUTO P-FDP is used in FDP testing to determine blood hyperfibrinolysis and hypercoagulable status. Important in testing for diagnosing disseminated intravascular coagulation (DIC) and thrombosis, the use of this reagent in conjunction with the D-dimer test is said to allow the type of DIC to be determined.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
6869:JP ¥3,650.00 JPY -80.00

6869 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bio-Rad Laboratories Inc $118.05 USD +0.01
BioMerieux €79.00 EUR -0.56
Mindray Medical International Ltd $30.78 USD 0.00
Nihon Kohden Corp ¥5,130 JPY -70.00
PerkinElmer Inc $46.86 USD +0.06
View Industry Companies

Industry Analysis


Industry Average

Valuation 6869 Industry Range
Price/Earnings 19.1x
Price/Sales -- Not Meaningful
Price/Book 5.4x
Price/Cash Flow 33.4x
TEV/Sales 4.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SYSMEX CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at